94 related articles for article (PubMed ID: 27394048)
1. A simple colorimetric assay for measuring fructosamine 3 kinase activity.
Cikomola JC; Kishabongo AS; Vandepoele K; Mulder M; Katchunga PB; Laukens B; Schie LV; Grootaert H; Callewaert N; Speeckaert MM; Delanghe JR
Clin Chem Lab Med; 2017 Jan; 55(1):154-159. PubMed ID: 27394048
[TBL] [Abstract][Full Text] [Related]
2. The association between fructosamine-3 kinase 900C/G polymorphism, transferrin polymorphism and human herpesvirus-8 infection in diabetics living in South Kivu.
Cikomola JC; Vandepoele K; Katchunga PB; Kishabongo AS; Padalko EY; Speeckaert MM; Delanghe JR
Acta Trop; 2016 Nov; 163():14-9. PubMed ID: 27461879
[TBL] [Abstract][Full Text] [Related]
3. A new HPLC-based assay for the measurement of fructosamine-3-kinase (FN3K) and FN3K-related protein activity in human erythrocytes.
Hellwig A; Scherber A; Koehler C; Hanefeld M; Henle T
Clin Chem Lab Med; 2014 Jan; 52(1):93-101. PubMed ID: 23648633
[TBL] [Abstract][Full Text] [Related]
4. A Potential Role for Fructosamine-3-Kinase in Cataract Treatment.
De Bruyne S; van Schie L; Himpe J; De Somer F; Everaert I; Derave W; Van den Broecke C; Huizing M; Bostan N; Speeckaert M; Callewaert N; Van Aken E; Delanghe JR
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917258
[TBL] [Abstract][Full Text] [Related]
5. Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites.
Delpierre G; Veiga-da-Cunha M; Vertommen D; Buysschaert M; Van Schaftingen E
Diabetes Metab; 2006 Feb; 32(1):31-9. PubMed ID: 16523184
[TBL] [Abstract][Full Text] [Related]
6. Fructosamine 3-kinase-related protein and deglycation in human erythrocytes.
Collard F; Wiame E; Bergans N; Fortpied J; Vertommen D; Vanstapel F; Delpierre G; Van Schaftingen E
Biochem J; 2004 Aug; 382(Pt 1):137-43. PubMed ID: 15137908
[TBL] [Abstract][Full Text] [Related]
7. Identification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin.
Delpierrre G; Vertommen D; Communi D; Rider MH; Van Schaftingen E
J Biol Chem; 2004 Jun; 279(26):27613-20. PubMed ID: 15102834
[TBL] [Abstract][Full Text] [Related]
8. Fructosamine-3-kinase-related-protein phosphorylates glucitolamines on the C-4 hydroxyl: novel substrate specificity of an enigmatic enzyme.
Szwergold B; Manevich Y; Payne L; Loomes K
Biochem Biophys Res Commun; 2007 Oct; 361(4):870-5. PubMed ID: 17686456
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic deglycation--a new paradigm or an epiphenomenon?
Szwergold BS; Beisswenger PJ
Biochem Soc Trans; 2003 Dec; 31(Pt 6):1428-32. PubMed ID: 14641081
[TBL] [Abstract][Full Text] [Related]
10. Fructosamine-6-phosphates are deglycated by phosphorylation to fructosamine-3,6-bisphosphates catalyzed by fructosamine-3-kinase (FN3K) and/or fructosamine-3-kinase-related-protein (FN3KRP).
Szwergold BS
Med Hypotheses; 2007; 68(1):37-45. PubMed ID: 16920277
[TBL] [Abstract][Full Text] [Related]
11. Some clues as to the regulation, expression, function, and distribution of fructosamine-3-kinase and fructosamine-3-kinase-related protein.
Conner JR; Beisswenger PJ; Szwergold BS
Ann N Y Acad Sci; 2005 Jun; 1043():824-36. PubMed ID: 16037310
[TBL] [Abstract][Full Text] [Related]
12. Evidence That Differences in Fructosamine-3-Kinase Activity May Be Associated With the Glycation Gap in Human Diabetes.
Dunmore SJ; Al-Derawi AS; Nayak AU; Narshi A; Nevill AM; Hellwig A; Majebi A; Kirkham P; Brown JE; Singh BM
Diabetes; 2018 Jan; 67(1):131-136. PubMed ID: 29066600
[TBL] [Abstract][Full Text] [Related]
13. Effects of fructosamine-3-kinase deficiency on function and survival of mouse pancreatic islets after prolonged culture in high glucose or ribose concentrations.
Pascal SM; Veiga-da-Cunha M; Gilon P; Van Schaftingen E; Jonas JC
Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E586-96. PubMed ID: 20009024
[TBL] [Abstract][Full Text] [Related]
14. Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo.
Szwergold BS; Howell S; Beisswenger PJ
Diabetes; 2001 Sep; 50(9):2139-47. PubMed ID: 11522682
[TBL] [Abstract][Full Text] [Related]
15. Increased protein glycation in fructosamine 3-kinase-deficient mice.
Veiga da-Cunha M; Jacquemin P; Delpierre G; Godfraind C; Théate I; Vertommen D; Clotman F; Lemaigre F; Devuyst O; Van Schaftingen E
Biochem J; 2006 Oct; 399(2):257-64. PubMed ID: 16819943
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic toxicity of glucose, due to non-enzymatic glycation, is controlled in-vivo by deglycation systems including: FN3K-mediated deglycation of fructosamines and transglycation of aldosamines.
Szwergold BS
Med Hypotheses; 2005; 65(2):337-48. PubMed ID: 15922110
[TBL] [Abstract][Full Text] [Related]
17. Role of fructosamine-3-kinase in protecting against the onset of microvascular and macrovascular complications in patients with T2DM.
Sartore G; Ragazzi E; Burlina S; Paleari R; Chilelli NC; Mosca A; Avemaria F; Lapolla A
BMJ Open Diabetes Res Care; 2020 May; 8(1):. PubMed ID: 32467223
[TBL] [Abstract][Full Text] [Related]
18. Possible role of fructosamine 3-kinase genotyping for the management of diabetic patients.
Avemaria F; Carrera P; Lapolla A; Sartore G; Chilelli NC; Paleari R; Ambrosi A; Ferrari M; Mosca A
Clin Chem Lab Med; 2015 Aug; 53(9):1315-20. PubMed ID: 26352355
[TBL] [Abstract][Full Text] [Related]
19. A mammalian protein homologous to fructosamine-3-kinase is a ketosamine-3-kinase acting on psicosamines and ribulosamines but not on fructosamines.
Collard F; Delpierre G; Stroobant V; Matthijs G; Van Schaftingen E
Diabetes; 2003 Dec; 52(12):2888-95. PubMed ID: 14633848
[TBL] [Abstract][Full Text] [Related]
20. Plant ribulosamine/erythrulosamine 3-kinase, a putative protein-repair enzyme.
Fortpied J; Gemayel R; Stroobant V; van Schaftingen E
Biochem J; 2005 Jun; 388(Pt 3):795-802. PubMed ID: 15705060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
